Dopamine is the most readily oxidized and in vitro the therapy.
groups on cysteine and glutathione to form the SH conMethods. Cysteinyl-dopamine and catecholamines were meajugates 5-S-glutathionyl-dopamine (GSH-DA) and 5-Ssured by high-performance liquid chromatography with electrocysteinyl-dopamine (CYS-DA) [4, 5] . Conjugation of dochemical detection. The production of cysteinyl-dopamine by pamine-quinone with ϪSH occurs 1000-fold faster than purified human neutrophils was measured using dopamine production of aminochrome by internal cyclization [6] .
(1 mol/L) and cysteine (1 mmol/L) concentrations similar to those found during dopamine treatment. To examine the imFormation of covalent bonds between dopamine-quipact of endotoxic shock on cysteinyl-dopamine production, none and nucleophilic ϪSH groups on proteins may disanesthetized rats were given dopamine (12 to 15 g/kg/min rupt protein structure and enzyme activity. In addition, intravenously) with or without endotoxin (50 mg/kg intravethe oxidation of CYS-DA produces a variety of neuronously).
Results. In vitro, neutrophils converted 26% of dopamine toxic products such as dihydrobenzothiazines and benzoto cysteinyl-dopamine (30 min at 37ЊC). Activating neutrophils thiazines [7] [8] [9] . These substances are lethal when injected with zymogen increased dopamine consumption from 26 to into the brains of mice [10] .
68%, but only 36% appeared as cysteinyl-dopamine. The re-
Conditions that produce cytotoxic dopamine thiolmainder may have been oxidized to other cysteinyl derivatives.
conjugates may exist when dopamine is used to treat
Endotoxin increased cysteinyl-dopamine in rat plasma from 2.5 nmol/L (range Ͻ0.2 to 11) to 9.7 nmol/L (range Ͻ0.3 to 31, patients with septic or cardiovascular shock. Intravenous P ϭ 0.1). After four hours, with or without endotoxin, cysteinyldopamine infusion for hours to days raises plasma uncondopamine was Ͻ0.3 nmol/L in cerebrospinal fluid. In the plasma jugated dopamine concentrations to the micromolar of eight patients receiving dopamine (6 to 20 g/kg/min for 1 range. Free radicals generated by activated neutrophils to 3 days), dopamine was 0.5 to 9.9 mol/L, and cysteinyldopamine was 48 to 1660 nmol/L. Cysteinyl-dopamine was 4.3 [11] or from reperfusion after ischemia [11] [12] [13] could to 22.6% of dopamine and correlated with leukocyte count (r 2 ϭ increase dopamine oxidation and the production of do-0.388, P ϭ 0.099).
pamine thiol-conjugates. This hypothesis was tested by at 95ЊC before extraction. The detection and quantitation of CYS-DA were satisfactory using both systems. Norada). Citric acid was obtained from JT Baker Chemical Co. (Phillipsburg, NJ, USA). Acetonitrile high-perforepinephrine and GSH-DA had virtually identical retention times when analyzed by the JCL6000 system (about mance liquid chromatography (HPLC) grade and sodium phosphate were purchased from Caledonian Labora-5 min), but the peaks were well separated using the Millennium system (ϳ6.5 and 40 min, respectively). Contories Ltd. (Georgetown, Ontario, Canada). Dibutylamine was obtained form Aldrich Chemical Co. (Milsequently, CYS-DA and GSH-DA were identified in biological samples by a comparison of retention times waukee, WI, USA).
on both HPLC systems and by co-chromatography with Catecholamine and 5-S-cysteinyl dopamine analysis standards. Recovery of all catecholamines with the exception of dihydroxyphenyl acetate (DOPAC) was beCatecholamine analysis was performed using HPLC with electrochemical detection. To increase analytical tween 65 and 85% following alumina extraction. The recovery of DOPAC was consistently approximately specificity, two different HPLC systems were used, with different detector voltages, mobile phase composition, 50%. Interassay coefficients of variation were dihydroxyphenylglycol (DHPG) 6.0%, DOPA 3.1%, NE 2.8%, E and pH. The JCL6000 system (Jones Chromatography USA Ltd., Lakeword, CO, USA) used a guard column 4.6%, DOPAC 8.5%, dopamine 7.2%, CYS-DA 3.3%, and GSH-DA 2.8% (N ϭ 10). The detection limit of both filled with C18 pellicular packing (Alltech Associates, Deerfield, IL, USA) and a 3 m packing LC-18 Sup-CYS-DA and GSH-DA (assuming 1.0 mL of undiluted specimen was processed) was 0.1 nmol/L. Linearity was elcosil 4.6 ϫ 75 mm column (Supelco Canada Ltd., Oakville, Ontario, Canada). The mobile phase was confirmed up to 200 nmol/L. CYS-DA was stable to hydrolysis, but 99% of GSH-DA was destroyed by the 50 mmol/L sodium acetate, 22.4 mmol/L citric acid, 1.35 mmol/L EDTA, 3.75 mmol/L sodium octane sulfoprocedure; therefore, we were unable to measure conjugated GSH-DA. Both GSH-DA and CYS-DA were nate, 0.01% (wt/vol) dibutylamine, and 4.5% (vol/vol) acetonitrile, adjusted to pH 4.3 to 4.4 with acetic acid, stable at acid pH (HClO 4 , pH 1.1) and room temperature. Standard solutions of GSH-DA and CYS-DA were filtered (4.5 m), and degassed. The flow rate was 0.7 mL/ min at an operating pressure of 9.4 Mpa (1200 psi). The stored at Ϫ70ЊC in 2 mol/L HCl. To produce 5-S-cysteinyl dopamine, dopamine-HCl HPLC was connected to a Model 5100A coulometric detector consisting of three coulometric cells in series (20 mg, 0.105 mmol) and l-cysteine (35 mg, 0.22 mmol) were incubated with mushroom tyrosinase (10 mg, 10,000 (ESA Inc., Bedford, MA, USA). The conditioning cell was set at 0.15 V. Analytical cell electrodes I and II were units) in 50 mL of 0.5 mol/L phosphate buffer (pH 6.5) [4] . After 60 minutes, a dopamine peak was no longer set at 0.2 and Ϫ0.38 V, respectively. Data analysis was performed by a JCL6000 Chromatography Data System detectable by HPLC, and the enzymatic reaction was stopped by adding 5 mL of 4 mol/L HClO 4 . CYS-DA (Jones Chromatography USA Ltd.) connected to electrode II.
was isolated by elution with 2 mol/L HCl from a Dowex-50 W-X4 (200 to 400 mesh hydrogen form) column. A The Millennium HPLC system used a Zorbax C18 column with an online filter. The mobile phase consisted dark purple residue with ultraviolet absorption maxima at 255 and 292 nm was obtained. Nuclear magnetic resoof 100 mmol/L sodium phosphate, 0.27 mmol/L EDTA, 0.92 mmol/L sodium octane sulfonate, and 3.0% (vol/vol) nance (NMR) spectral analysis confirmed that the compound was CYS-DA. To produce 5-S-glutathionyl dopaacetonitrile and was adjusted to pH 3.6 with phosphoric acid and degassed. The flow rate was 1.0 mL/min at an mine, dopamine HCl (40 mg, 0.21 mmol) and glutathione (700 mg, 2.28 mmol) were incubated with mushroom operating pressure of 9.4 Mpa (1200 psi). The HPLC was connected to a Model Coulochem II coulometric tyrosinase (10 mg, 10,000 U) in 25 mL of 0.1 mol/L ammonium acetate buffer (pH 5.8) for five hours [5] . A detector consisting of four coulometric cells in series (ESA Inc.). The guard cell was set at 0.15 V. Electrodes brown substance was obtained was eluted with 2 mol/L HCl from a Dowex column. UV maxima were at 255 I, II, III, and IV were set at 0.0, 0.0, 0.20 and Ϫ0.38 V, respectively. Data analysis was performed by a Millenand 292 nm [4, 5] , and NMR spectral analysis confirmed that the compound was GSH-DA. S-(N-acetylcysteinyl)-nium 2020 chromatography manager (Waters Associates Inc., Millford, MA, USA).
dopamine was synthesized by electrolysis of dopamine to produce dopamine-o-quinone followed by addition of Catecholamines and their metabolites, including CYS-DA and GSH-DA, were extracted from plasma N-acetyl cysteine [8] . The major product of this reaction has been identified by Shen, Zhang, and Dryhurst as 5-Sand urine with alumina. Catecholamines were released (N-acetylcysteinyl)-dopamine [8] . The reaction mixture method of Huang et al [14] . The rats were then infused was extracted with alumina and separated with HPLC.
with dopamine (15 g/kg/min) for four to five hours. The major unidentified peak appeared midway between Four of the rats also received 50 mg of endotoxin at the the dopamine and CYS-DA peaks on the Millennium beginning of the dopamine infusion. CSF was collected system. during the final two hours of the infusion. An additional six anesthetized rats were infused with dopamine for five Incubation of 5-S-cysteinyldopamine with hours without the cisternal catheter, and three of these activated neutrophils rats also received endotoxin. Urine was collected during Activated neutrophils were prepared from citrated the fourth hour of the dopamine infusion. Samples were blood obtained from human volunteers. All reagents immediately centrifuged, separated into 1 mL aliquots, were sterile. Blood was centrifuged for 20 minutes at and stored at Ϫ70ЊC until analysis. 175 ϫ g, and the plasma was removed down to the buffy coat. This plasma was layered onto a button of 90% Cysteinyldopamine in plasma from patients receiving percoll and centrifuged at 1000 ϫ g to produce plateletintravenous dopamine poor plasma. After removal of the plasma, the remaining After obtaining informed consent or surrogate incells were resuspended with 5 mL of 6% dextran T-500 formed consent, heparinized blood samples (7 mL) were in 0.9% wt/vol saline, made up to 50 mL with saline, and collected from eight critically ill patients who were reallowed to stand for 30 minutes. The supernatant was ceiving intravenous dopamine (6 to 20.5 g/kg/min) at then centrifuged at 112 ϫ g for six minutes at room the Toronto General Hospital Division of the University temperature. The resulting pellet was resuspended in Health Network. The samples were centrifuged immedi-2 mL of platelet-poor plasma and underlayered with 51 ately at 4ЊC and stored at Ϫ70ЊC until analysis. This and 42% percoll gradients. The cells and percoll were study was approved by the UHN Research Ethics Board. centrifuged at 180 ϫ g for 10 minutes, and then the neutrophil-enriched intermediate layer was washed in Statistics Hank's solution containing 110 U/L heparin. The cells Data were calculated using SigmaStat for Windows were used immediately for further experiments; 10 7 neu-(Jandel Scientific Software, San Rafael, CA, USA). A trophils were incubated in 1 mL of Hank's solution with comparison of catecholamine results between the groups 1 mol/L cysteine and 1 mol/L dopamine with or without was assessed by Kruskal-Wallis one-way analysis of variopsinized zymogen (25 L) to activate them. These concentrations of cysteine and dopamine are typically enance (ANOVA) on ranks, followed by the Student Newcountered in the plasma of septicemic patients undergoman-Keuls multiple comparison procedure to isolate the ing dopamine therapy. After 30 minutes at 37ЊC, the groups or groups that differed from the others. Statistical reaction was stopped with 40 L of 70% HClO 4 . Catesignificance was considered at P values of Յ0.5. cholamines were measured in the supernatant after alumina extraction. All assays were performed in triplicate.
RESULTS Dopamine infusion into endotoxin-shocked rats
Incubation of 5-S-cysteinyldopamine with Male Wistar rats (310 to 350 g) were used to test the activated neutrophils effect of endotoxic shock on the production of GSHIn the absence of neutrophils, 26 nmol/L (2.6%) of DA and CYS-DA during dopamine infusion. Twentydopamine were converted to CYS-DA (Fig. 1) . The addifour animals were anesthetized (50 mg/kg pentobarbitol tion of neutrophils to the incubation mixture increased IP), catheterized, and infused for 60 minutes with 0.9% the conversion of dopamine to CYS-DA by 10-fold to wt/vol saline (3 mL/hour). Systolic blood pressure was 255 nmol/L (26% of initial dopamine concentration). monitored continuously through a cannula in the carotid After neutrophil activation by zymogen, 680 nmol/L of artery during the study. Groups 1 and 2 were given an IV dopamine disappeared; however, the CYS-DA concenbolus injection of Escherichia coli endotoxin-serotype tration only increased to 364 nmol/L (36% of initial do-055:B5 (50 mg/kg body weight)-in 500 L saline. pamine concentration). Therefore, in an environment of Groups 2 and 4 were given saline. After five minutes, increased free radical production, the disappearance of groups 1 and 3 were infused with dopamine (12 g/kg/ dopamine substantially exceeded the measured appearmin) for 30 minutes. Groups 2 and 4 were infused with ance of CYS-DA. Apart from dopamine and CYS-DA, saline. Blood (6 mL) was then taken for catecholamine no other metabolites were detected, except a minor unmeasurement. Another group of eight rats was anestheidentified peak that was possibly a CYS-DA oxidation tized with inactin (100 mg/kg, IP) and prepared for colproduct. This peak was also observed in the CYS-DA lection of cerebrospinal fluid (CSF). A catheter was implanted in each rat's cisterna magna following the standard.
nephrine above that seen with endotoxin or dopamine alone. CYS-DA was undetectable in plasma of rats that did not receive dopamine. GSH-DA was not detected in any of the plasma samples. Similar results were obtained after five hours of dopamine infusion ( Table 2 ). At that time, plasma dopamine levels were lower, but the difference was not significant. An unknown peak with the same retention time as the major product from the reaction of dopamine-oquinone with N-acetylcysteine [8] appeared in chromatographs of plasma from rats that received dopamine. The unknown peak was not found in urine or in plasma from control rats that did not receive dopamine. The peak height was similar to that of CYS-DA. In rats that received dopamine, endotoxin did not alter the mean peak height of the unknown substance (67 Ϯ 31 V after 30 peak (P ϭ 0.06 in the group that received endotoxin and P ϭ 0.14 in the group that received dopamine without endotoxin). There was no correlation of the unknown peak with CYS-DA dopamine in the plasma collected Dopamine infusion into endotoxin-shocked rats after four to five hours of infusion. Systolic blood pressure was between 100 and 145
Urine excretion decreased to virtually zero for the first mm Hg during the one-hour stabilization period prior hour following the injection of endotoxin; therefore, we to endotoxin or saline injection. During the 10 minutes only examined the results for rats that received four to following endotoxin injection, blood pressure decreased five hours of dopamine infusion. In preliminary studies to 30% of baseline values in rats that received dopamine with dopamine infused rats, we found that urine free and those that did not. Blood pressure increased over CYS-DA was 23 Ϯ 10% of total CYS-DA. Urine volume the next 20 minutes to approximately 60% of baseline was too small to measure total as well as free CYS-DA values and remained there for up to 4.5 hours. Blood in the endotoxin-treated rats. Endotoxin increased the pressure did not alter significantly from baseline in the excretion of norepinephrine and epinephrine during dogroups that received saline or dopamine without endopamine infusion (Table 3) , but did not significantly alter toxin throughout the experiment. Hematocrit levels inthe excretion of dopamine or CYS-DA. Urinary-free creased significantly (P Ͻ 0.001) in rats that received CYS-DA excretion did not correlate with plasma dopaendotoxin but did not change in the others. mine or CYS-DA, but was correlated with plasma norIntravenous dopamine, by itself within 30 minutes, epinephrine (P ϭ 0.02) and epinephrine (P ϭ 0.007) in raised plasma concentrations of dopamine and CYS-DA the group that received both endotoxin and dopamine. as well as the metabolites, DHPG and DOPAC (Table 1) .
Cerebrospinal fluid was collected during the final two Endotoxin, by itself, increased DHPG, DOPA, norepihours of four-to five-hour dopamine infusions (Table 4) . nephrine, epinephrine, and DOPAC, but not CYS-DA CYS-DA was below the level of detection in all samples. concentration. CYS-DA concentrations were not norEndotoxin did not increase the CSF concentrations of mally distributed in rats that received dopamine alone. dopamine or its metabolites. High CYS-DA concentrations were associated with tranCatecholamine analysis of plasma from patients sient incomplete anesthesia in two rats that did not rereceiving intravenous dopamine ceive endotoxin. The superimposition of intravenous dopamine on endotoxic shock increased plasma CYS-DA, Using both HPLC systems, CYS-DA was identified in but because of the wide scatter of results the median plasma from eight patients that were receiving dopamine concentration (9.7 nmol/L), was not significantly higher for a variety of acute critical conditions ( Table 5 ). The than with dopamine alone (2.3 nmol/L, P ϭ 0.13, Mann-CYS-DA concentration was related to plasma dopamine Whitney rank sum test). The combination of endotoxin concentration (r 2 ϭ 0.97). Plasma CYS-DA as a percentage of dopamine tended to increase with white blood cell and dopamine increased the concentration of norepi- Median concentration is in nmol/L with 25 to 75% confidence limits. Abbreviations are: DHPG, dihydroxy phenylglycol; DOPA, dihydoxyphenylalanine; E, epinephrine; NE, norepinephrine; DA, dopamine; CYS-DA, 5-S-cysteinyl-dopamine. Endotoxin (50 mg/kg) was injected into groups 1 and 2, while groups 1 and 3 received dopamine (12-15 g/kg·min IV). Blood was collected after 30 minutes of dopamine infusion with or without endotoxin or saline control. One-way ANOVA on ranks P Ͻ 0.05. N ϭ 5 to 9 in each group. a Significantly greater than group 4 (P Ͻ 0.05) b Significantly greater than group 2 (P Ͻ 0.05) c Significantly greater than group 3 (P Ͻ 0.05) Median concentration is in nmol/L with 25 to 75% confidence limits. Abbreviations are: DHPG, dihydroxy phenylglycol; DOPA, dihydoxyphenylalanine; E, epinephrine; NE, norepinephrine; DA, dopamine; CYS-DA, 5-S-cysteinyl-dopamine. Endotoxin (50 mg/kg) was injected into one group (N ϭ 7) and the other group received only saline (N ϭ 6). Both groups received dopamine (15 g/kg/min IV). Blood was collected after 300 minutes of dopamine infusion with or without endotoxin or saline control. P values are for an unpaired t test with DHPG and NE. Other metabolites were not significantly different.
a P ϭ 0.02, b P ϭ 0.03 Mean Ϯ SE excretion rates pmol/min. Dopamine was infused at 15 g/kg/min into 5 rats. Urine was collected during the fourth hour of dopamine infusion, another 7 rats received dopamine plus endotoxin 50 mg/kg. P values are for an unpaired t test. Abbreviations are in the Table 2 legend. a P ϭ 0.03, b P ϭ 0.02 Table 4 . Catecholamine metabolites in cerebrospinal collected during dopamine infusion with and without endotoxin
Data are means Ϯ SE; concentration is in nmol/L. Dopamine was infused at 15 g/kg/min into 4 rats. Another 4 rats received dopamine plus endotoxin 50 mg/kg. Cerebrospinal fluid (CSF) was collected during the second to fourth hour of dopamine infusion from both groups.
(WBC) count (P ϭ 0.099; Fig. 2 ). Using stepwise forward fied peak appeared midway between dopamine and CYS-DA in the patient's plasma. This unknown peak regression analysis, the equation relating %CYS-DA/ dopamine to WBCs was not significantly improved by addthat may have been an N-acetyl cysteinyl-dopamine conjugate was smaller than the CYS-DA peaks. ing plasma dopamine, dopamine dose, duration of treatment, or arterial pO 2 . There was no significant relationship In theory, dopamine should react with GSH as well as with cysteine. An explanation for the absence of GSH-DA with the nature of the primary diagnosis. GSH-DA was not detected in any of the plasma samples. An unidentifrom the rat and human samples was sought by adding Concentration is in nmol/L. Glutathionyl-dopamine (GSH-DA) was added to pooled plasma with high (270 U/L) or low (10 U/L) ␥-glutamyl transpeptidase activity. Acivicin (1.5 mg/mL) was added to a paired sample to inhibit ␥-glutamyl transpeptidase activity.
GSH-DA to pooled human plasma with high ␥-glutamyl transpeptidase (␥-GT) activity (279 U/L). GSH dopamine (initially 860 nmol/L of plasma) was rapidly degraded and more than 80% disappeared after 30 minutes of incubation. The CYS-DA concentration increased from Ͻ0.15 nmol/L to 108 nmol/L after 30 minutes. Preincubation of the pooled plasma with acivicin to block ␥-GT activity slowed the degradation of GSH-DA and CYS-DA production so that after 30 minutes, 808 nmol/L of GSH-DA remained and CYS-DA had only increased to 16 nmol/L (Table 6 ). Plasma with a low ␥-GT concentration did not produce CYS-DA, although GSH-DA disappeared. In this plasma, the removal of GSH-DA was not sensitive to inhibition by acivicin. paths. It may (1) form conjugates with nucleophilic groups such as the ϪSH on cysteine or proteins, (2) undergo of the plasma-free dopamine concentration. That neutrophils promote dopamine conjugation with cysteine is intramolecular cyclization, or (3) be reduced back to the original catechol with the production of free oxygen suggested by the correlation between the percentage of CYS-DA/dopamine and WBC count (P ϭ 0.099; Fig. 2 ). radicals [1, 6, 16] . Dopamine-quinone is 1000 times more likely to react with nucleophilic ϪSH groups if they are CYS-DA is only one product of many created by dopamine-quinone interaction with ϪSH groups [7] [8] [9] [10] 18] . available than to undergo intramolecular cyclization to produce an indoline [6] . The neutrophil experiments
The presence of conjugated CYS-DA in rat urine suggests that an additional pool of conjugated CYS-DA was demonstrated the avidity of dopamine for ϪSH groups (Fig. 1) . Neutrophils rapidly converted 26% of dopamine present in both rat and human plasma. Up to 70% of oxidized dopamine may bind to protein ϪSH groups to CYS-DA when dopamine and cysteine concentrations were similar to those that exist in critically ill patients [19] . Thus, we conclude that the free CYS-DA represents only a small portion of the total DA-SH conjugates during treatment with dopamine (Table 5 ). Neutrophil activation doubled the rate of dopamine disappearance formed by nucleophilic attack on oxidized dopamine in these patients. with a 10% increase in CYS-DA production. The small increase in CYS-DA is to be expected because CYS-DA During dopamine therapy, plasma dopamine concentrations are frequently greater than 1 mol/L (Table 5) , is more easily oxidized than dopamine. Oxidized CYS-DA is converted to a variety of thiol-conjugates and their which is 1% of the LD 50 for some cells in culture [20] . These concentrations of dopamine can alter protein acetylated conjugates [7, 8, 10, 16] .
The production of CYS-DA in anesthetized rats was structure and inactivate enzymes such as DNA polymerase [21] and other ϪSH dependent proteins [22] . Oxidameasured after dopamine infusion for 30 to 300 minutes. At both 30 and 300 minutes, the unconjugated CYS-DA tion of CYS-DA produces dihydoxybenzothiazine, which is lethal when injected into the mouse brain [16] . Cysteiconcentration was approximately 1% of the plasma dopamine concentration (Tables 1 and 2 ). After three to nyl-DOPAC, derived from the reaction of cysteine with oxidized DOPAC, is highly toxic to cultured P19 cells five hours of dopamine infusions, there was no detectable CYS-DA in CSF and CSF dopamine concentration was and to hippocampal pyramidal neurons [9] . It is interesting to note that DOPAC concentrations increased 50-less than 10% of plasma concentration (Table 4) . Conjugated CYS-DA was not measured in plasma but was fold during the 30-minute dopamine infusion following endotoxin injection (Table 1) ; however, we did not look found to be 23% of total CYS-DA in urine after acid hydrolysis. Dopamine-quinone reacts avidly with glutafor cysteinyl-DOPAC specifically. The concentration of CYS-DA may be viewed in two thione as well as with cysteine [6] ; however, no GSH-DA was found in plasma or urine. The absence of GSH-DA ways: as an index of dopamine-quinone interaction with ϪSH groups in general and as a reflection of the protecis consistent with its rapid conversion to CYS-DA by ␥-glutamyl transpeptidase (Table 6) [17] and to acetyltive effect of cysteine and glutathione. Glutathione and cysteine, by forming thiol-conjugates with dopamine, reated thiol-conjugates by cysteine conjugate acetyl transferase [8] .
duce the binding of dopamine to protein ϪSH groups [23] . This protective action is shown by reduced dopaEndotoxemia did not significantly increase the conversion of infused dopamine to CYS-DA in plasma or urine.
mine-induced apoptosis in cultured PC12 cells [24] . However, while glutathione may reduce the reaction of dopaInterpretation of these experiments is confounded by sustained hypotension, which would have impaired renal mine with protein-SH groups, it does not necessarily protect against the cellular disruption produced by high metabolism and clearance of dopamine. Furthermore, oxidative destruction of both dopamine and CYS-DA concentrations of dopamine [23] , and as previously noted, a number of the byproducts of GSH-DA and may have increased as it did in the neutrophil experiments (Fig. 1) [16] . Variable degrees of oxidative stress CYS-DA may be cytotoxic [7] [8] [9] [10] 18 ]. We conclude that thioester formation contributes sigcould contribute to the wide range of plasma CYS-DA concentrations and the consequent lack of a significant nificantly to the metabolism of dopamine during dopamine therapy. Factors that promote oxidation of dopadifference between the control and endotoxin treated rats. Endotoxemia did not significantly increase the conmine such as activated neutrophils will increase the formation of dopamine-thiol-conjugates. The literature centration of dopamine or CYS-DA in CSF, which suggests that at least for brief dopamine infusions with an indicates that some of the oxidized derivatives of CYS-DA that are produced have toxic effects on the intact blood-brain barrier, the risk of central nervous system exposure to dopamine and its conjugates is not great.
brain. However, we found no evidence of CYS-DA in the CSF during intravenous infusion of dopamine for CYS-DA appeared in the plasma (Table 5) and urine (not shown) of critically ill patients undergoing treatseveral hours in endotoxemic rats. The extent to which the oxidized derivatives of CYS-DA are toxic outside ment with dopamine. Concentrations of free CYS-DA were in the mol/L range and ranged from 4 to 22.6% the brain is not known. One clinical report suggests that
